Clinicopathological Spectrum of Acute Myeloid Leukemia and Treatment Outcomes in Kashmiri Population: A Prospective
Afaq Ahmad Khan1, Sajad Ahmed Geelani1, Santosh Govind Rathod2
1Department of Clinical Hematology, SKIMS, Srinagar, Jammu and Kashmir, India.
Introduction And Aims:
The prognosis for acute myeloid leukemia (AML) in adults is poor. The epidemiologic profile of patients varies substantially across geographic locales, as do the cytogenetic abnormalities and FAB subtype of AML. Kashmiris are a genetically conserved population. In this study, we are investigating clinical and laboratory factors and outcomes to establish treatment protocols.
Methodology:
This was a prospective study with clinical profiles and laboratory parameters of 100 case records. The primary objectives were to know the demographic profile of AML, prevalence of various FAB subtypes, cytogenetic abnormalities, and induction outcomes at our centre.
Results:
Median age was 50 years. The most common FAB subtype observed was AML M2. Pallor was observed in all patients as a clinical sign, while splenomegaly was noted in 41%, hepatomegaly in 23%, lymphadenopathy in 7%, and extramedullary disease in 6%. The ELN risk stratification for patients who have received 3 + 7 demonstrated a significant influence on complete remission rates (P = 0.004).
Conclusions:
Survival correlated significantly with risk stratification (P = 0.048), Eastern Cooperative Oncology Group score (P = 0.002), and age (P = 0.041). Median overall survival was 13.7 months, with 52% all-cause mortality.
Related Concept Videos
02:56Treatment Resistent Cancers
02:56Treatment Resistant Cancers
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...